Additionally, surface modification of nanoparticles to incorporate immune stimulation such as the use of an anti-CD40 monoclonal antibody, has been shown to induce potent CD8+ T cell responses resulting in tumour growth attenuation and prolonged survival in preclinical models [118,119]. Here, CD8A is linked to neoplasm.